GEHC Q2 Deep Dive: Product Innovation and Service Strength Propel Growth Amid PCS Challenges
GE HealthCare Technologies (GEHC) Looks Re Rated After Strong Q2 And Record Backlog
GE HealthCare (GEHC) Stock Looks Reasonable On Earnings But Stretched On Fair Value
Evercore ISI Group Maintains Outperform on GE HealthCare Techs, Raises Price Target to $84
Wells Fargo Maintains Overweight on GE HealthCare Techs, Raises Price Target to $85
GE HealthCare: Strong Demand, Weak Execution - Why The Backlog Matters More (Rating Upgrade)
GE HealthCare Technologies Inc. 2026 Q2 - Results - Earnings Call Presentation
Loading...